Back to Results
First PageMeta Content
Anti-diabetic drugs / Health / Eli Lilly and Company / Nutrition / Anti-diabetic medication / Diabetes management / Exenatide / Glycated hemoglobin / Obesity / Diabetes / Medicine / Endocrine system


Clinical Trials and Biostatistics Unit – QIMR Berghofer Medical Research Institute Topic: Evaluation of the obesity paradox in diabetes: A longitudinal case-control study International collaborators: Imperial College L
Add to Reading List

Document Date: 2015-02-02 20:44:45


Open Document

File Size: 295,95 KB

Share Result on Facebook

Company

Amylin Pharmaceuticals LLC / Chinese Scoring Systems / Bristol-Myers Squibb / /

Country

United Kingdom / China / /

/

Event

FDA Phase / /

Facility

Imperial College / QIMR Berghofer Medical Research Institute / University of Leicester / Peking University / /

IndustryTerm

Treatment of diabetes / /

MedicalCondition

diabetes mellitus / obesity / chronic disease / incident diabetes / metabolic diseases / disease / pre-existing cardiovascular and non-cardiovascular disease / non-cardiovascular diseases / cardiovascular diseases / diabetes / /

MedicalTreatment

Chinese Traditional Medicine / Traditional Chinese Medicine / /

Organization

Peking University / University of Leicester / Imperial College London / QIMR Berghofer Medical Research Institute / Clinical Trials and Biostatistics Unit / /

Person

Sanjoy Paul / Ji / /

Position

Professor / Principal Investigator / Head / /

Product

Xiaoke Pill / GLP-1R / /

PublishedMedium

PLoS One / /

SocialTag